Health
Vaccines for SARS coronavirus 2 and the new normal in vaccinology – Wiley
Click on the article title to read more.
Severe acute respiratory syndrome coronavirus 2 (SARSCoV2) causes an acute infection that is controlled by the immune response. The virus has a dominant surface protein that is highly immunogenic and it can be presumed that neutralising antibodies will prove to be the correlate of protection, supported by cellmediated immunity.1 It should therefore be straightforward to produce a vaccine against this novel virus.
This perspective has turned out to be true, but it is the pace with which the vaccines…
-
Noosa News10 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News11 hours agoMotorcyclist dies in crash with truck
-
Noosa News11 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General16 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging